{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T03:37:44Z","timestamp":1784259464753,"version":"3.55.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T00:00:00Z","timestamp":1750204800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T00:00:00Z","timestamp":1750204800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1007\/s10620-025-09137-1","type":"journal-article","created":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T11:03:44Z","timestamp":1750244624000},"page":"3730-3742","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["PDHA1 Orchestrates Hepatocellular Carcinoma Progression Through LINC00607-Mediated Regulation of Cuproptosis and Immune Evasion"],"prefix":"10.1007","volume":"70","author":[{"given":"Libai","family":"Lu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yufei","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zongjiang","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenrong","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiasheng","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianchu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,18]]},"reference":[{"key":"9137_CR1","doi-asserted-by":"publisher","first-page":"918869","DOI":"10.3389\/fendo.2022.918869","volume":"13","author":"Z Guizhen","year":"2022","unstructured":"Guizhen Z, Guanchang J, Liwen L, Huifen W, Zhigang R, Ranran S et al. The tumor microenvironment of hepatocellular carcinoma and its targeting strategy by CAR-T cell immunotherapy. Front Endocrinol (Lausanne). 2022;13:918869.","journal-title":"Front Endocrinol (Lausanne)."},{"key":"9137_CR2","doi-asserted-by":"publisher","first-page":"3430","DOI":"10.1002\/cncr.30237","volume":"122","author":"SP Choo","year":"2016","unstructured":"Choo SP, Tan WL, Goh BKP, Tai WM, Zhu AX. Comparison of hepatocellular carcinoma in Eastern versus Western populations. Cancer. 2016;122:3430\u20133446.","journal-title":"Cancer."},{"key":"9137_CR3","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1002\/hep.31288","volume":"731 Suppl 1","author":"KA McGlynn","year":"2021","unstructured":"McGlynn KA, Petrick JL, El-Serag HB. Epidemiology of hepatocellular carcinoma. Hepatology. 2021;731 Suppl 1:4\u201313.","journal-title":"Hepatology."},{"key":"9137_CR4","doi-asserted-by":"publisher","first-page":"5217","DOI":"10.3748\/wjg.v28.i35.5217","volume":"28","author":"EA Mohamed","year":"2022","unstructured":"Mohamed EA, Giama NH, Abdalla AO, Shaleh HM, Oseini AM, Ali HA et al. High prevalence of chronic viral hepatitis B and C in Minnesota Somalis contributes to rising hepatocellular carcinoma incidence. World J Gastroenterol. 2022;28:5217\u20135229.","journal-title":"World J Gastroenterol."},{"key":"9137_CR5","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/s41572-020-00240-3","volume":"7","author":"JM Llovet","year":"2021","unstructured":"Llovet JM, Kelley RK, Villanueva A, Singal AG, Pikarsky E, Roayaie S et al. Hepatocellular carcinoma. Nat Rev Dis Primers. 2021;7:6.","journal-title":"Nat Rev Dis Primers."},{"key":"9137_CR6","doi-asserted-by":"publisher","first-page":"2081","DOI":"10.1136\/gutjnl-2021-325109","volume":"71","author":"JN Sondergaard","year":"2022","unstructured":"Sondergaard JN, Sommerauer C, Atanasoai I, Hinte LC, Geng K, Guiducci G et al. CCT3-LINC00326 axis regulates hepatocarcinogenic lipid metabolism. Gut. 2022;71:2081\u20132092.","journal-title":"Gut."},{"key":"9137_CR7","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s13045-018-0579-3","volume":"11","author":"S Li","year":"2018","unstructured":"Li S, Yao J, Xie M, Liu Y, Zheng M. Exosomal miRNAs in hepatocellular carcinoma development and clinical responses. J Hematol Oncol. 2018;11:54.","journal-title":"J Hematol Oncol."},{"key":"9137_CR8","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1007\/s10555-023-10084-4","volume":"42","author":"Y Wang","year":"2023","unstructured":"Wang Y, Deng B. Hepatocellular carcinoma: molecular mechanism, targeted therapy, and biomarkers. Cancer Metastasis Rev. 2023;42:629\u2013652.","journal-title":"Cancer Metastasis Rev."},{"key":"9137_CR9","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1159\/000343839","volume":"1","author":"RS Finn","year":"2012","unstructured":"Finn RS. Current and future treatment strategies for patients with advanced hepatocellular carcinoma: role of mTOR inhibition. Liver Cancer. 2012;1:247\u2013256.","journal-title":"Liver Cancer."},{"key":"9137_CR10","doi-asserted-by":"publisher","first-page":"101018","DOI":"10.1016\/j.drup.2023.101018","volume":"72","author":"Y Wang","year":"2024","unstructured":"Wang Y, Chen Y, Zhang J, Yang Y, Fleishman JS, Wang Y et al. Cuproptosis: a novel therapeutic target for overcoming cancer drug resistance. Drug Resist Updat. 2024;72:101018.","journal-title":"Drug Resist Updat."},{"key":"9137_CR11","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1111\/imr.13276","volume":"321","author":"WQ Liu","year":"2024","unstructured":"Liu WQ, Lin WR, Yan L, Xu WH, Yang J. Copper homeostasis and cuproptosis in cancer immunity and therapy. Immunol Rev. 2024;321:211\u2013227.","journal-title":"Immunol Rev."},{"key":"9137_CR12","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1126\/science.abf0529","volume":"375","author":"P Tsvetkov","year":"2022","unstructured":"Tsvetkov P, Coy S, Petrova B, Dreishpoon M, Verma A, Abdusamad M et al. Copper induces cell death by targeting lipoylated TCA cycle proteins. Science. 2022;375:1254\u20131261.","journal-title":"Science."},{"key":"9137_CR13","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1038\/nm730","volume":"8","author":"H Dong","year":"2002","unstructured":"Dong H, Strome SE, Salomao DR, Tamura H, Hirano F, Flies DB et al. Tumor-associated B7\u2013H1 promotes T-cell apoptosis: a potential mechanism of immune evasion. Nat Med. 2002;8:793\u2013800.","journal-title":"Nat Med."},{"key":"9137_CR14","doi-asserted-by":"publisher","first-page":"2492","DOI":"10.1016\/S0140-6736(17)31046-2","volume":"389","author":"AB El-Khoueiry","year":"2017","unstructured":"El-Khoueiry AB, Sangro B, Yau T, Crocenzi TS, Kudo M, Hsu C et al. Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1\/2 dose escalation and expansion trial. Lancet. 2017;389:2492\u20132502.","journal-title":"Lancet."},{"key":"9137_CR15","doi-asserted-by":"publisher","first-page":"16615","DOI":"10.1074\/jbc.R114.563148","volume":"289","author":"MS Patel","year":"2014","unstructured":"Patel MS, Nemeria NS, Furey W, Jordan F. The pyruvate dehydrogenase complexes: structure-based function and regulation. J Biol Chem. 2014;289:16615\u201316623.","journal-title":"J Biol Chem."},{"key":"9137_CR16","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1042\/bj3580069","volume":"358","author":"E Kolobova","year":"2001","unstructured":"Kolobova E, Tuganova A, Boulatnikov I, Popov KM. Regulation of pyruvate dehydrogenase activity through phosphorylation at multiple sites. Biochem J. 2001;358:69\u201377.","journal-title":"Biochem J."},{"key":"9137_CR17","doi-asserted-by":"publisher","first-page":"31146","DOI":"10.1038\/srep31146","volume":"6","author":"T Golias","year":"2016","unstructured":"Golias T, Papandreou I, Sun R, Kumar B, Brown NV, Swanson BJ et al. Hypoxic repression of pyruvate dehydrogenase activity is necessary for metabolic reprogramming and growth of model tumours. Sci Rep. 2016;6:31146.","journal-title":"Sci Rep."},{"key":"9137_CR18","first-page":"2955","volume":"40","author":"Z Liu","year":"2018","unstructured":"Liu Z, Yu M, Fei B, Fang X, Ma T, Wang D. miR-21-5p targets PDHA1 to regulate glycolysis and cancer progression in gastric cancer. Oncol Rep. 2018;40:2955\u20132963.","journal-title":"Oncol Rep."},{"key":"9137_CR19","doi-asserted-by":"publisher","first-page":"53837","DOI":"10.18632\/oncotarget.10782","volume":"7","author":"Y Li","year":"2016","unstructured":"Li Y, Li X, Li X, Zhong Y, Ji Y, Yu D et al. PDHA1 gene knockout in prostate cancer cells results in metabolic reprogramming towards greater glutamine dependence. Oncotarget. 2016;7:53837\u201353852.","journal-title":"Oncotarget."},{"key":"9137_CR20","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.7150\/ijbs.77133","volume":"19","author":"C Zhong","year":"2023","unstructured":"Zhong C, Long Z, Yang T, Wang S, Zhong W, Hu F et al. M6A-modified circRBM33 promotes prostate cancer progression via PDHA1-mediated mitochondrial respiration regulation and presents a potential target for ARSI therapy. Int J Biol Sci. 2023;19:1543\u20131563.","journal-title":"Int J Biol Sci."},{"key":"9137_CR21","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s10557-023-07501-9","volume":"39","author":"KY Chen","year":"2023","unstructured":"Chen KY, Liu Z, Yi J, Hui YP, Song YN, Lu JH et al. PDHA1 alleviates myocardial ischemia-reperfusion injury by improving myocardial insulin resistance during cardiopulmonary bypass surgery in rats. Cardiovasc Drugs Ther. 2023;39:17\u201331.","journal-title":"Cardiovasc Drugs Ther."},{"key":"9137_CR22","doi-asserted-by":"publisher","first-page":"1786","DOI":"10.1016\/j.molcel.2022.05.001","volume":"82","author":"PA Cobine","year":"2022","unstructured":"Cobine PA, Brady DC. Cuproptosis: cellular and molecular mechanisms underlying copper-induced cell death. Mol Cell. 2022;82:1786\u20131787.","journal-title":"Mol Cell."},{"key":"9137_CR23","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1038\/s41698-024-00724-5","volume":"8","author":"J Chen","year":"2024","unstructured":"Chen J, Li ZY, Zheng G, Cao L, Guo YM, Lian Q et al. RNF4 mediated degradation of PDHA1 promotes colorectal cancer metabolism and metastasis. NPJ Precis Oncol. 2024;8:258.","journal-title":"NPJ Precis Oncol."},{"key":"9137_CR24","doi-asserted-by":"publisher","first-page":"e59","DOI":"10.3802\/jgo.2023.34.e59","volume":"34","author":"L Zhao","year":"2023","unstructured":"Zhao L, Geng R, Huang Y, Zhang J, Cheng H, Zhou C et al. AP2alpha negatively regulates PDHA1 in cervical cancer cells to promote aggressive features and aerobic glycolysis in vitro and in vivo. J Gynecol Oncol. 2023;34:e59.","journal-title":"J Gynecol Oncol."},{"key":"9137_CR25","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1007\/s12079-022-00691-1","volume":"17","author":"AA Olou","year":"2023","unstructured":"Olou AA, Ambrose J, Jack JL, Walsh M, Ruckert MT, Eades AE et al. SHP2 regulates adipose maintenance and adipocyte-pancreatic cancer cell crosstalk via PDHA1. J Cell Commun Signal. 2023;17:575\u2013590.","journal-title":"J Cell Commun Signal."},{"key":"9137_CR26","doi-asserted-by":"publisher","first-page":"189013","DOI":"10.1016\/j.bbcan.2023.189013","volume":"1878","author":"X Liu","year":"2023","unstructured":"Liu X, Luo B, Wu X, Tang Z. Cuproptosis and cuproptosis-related genes: Emerging potential therapeutic targets in breast cancer. Biochim Biophys Acta Rev Cancer. 2023;1878:189013.","journal-title":"Biochim Biophys Acta Rev Cancer."},{"key":"9137_CR27","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/j.tips.2023.07.004","volume":"44","author":"L Yang","year":"2023","unstructured":"Yang L, Yang P, Lip GYH, Ren J. Copper homeostasis and cuproptosis in cardiovascular disease therapeutics. Trends Pharmacol Sci. 2023;44:573\u2013585.","journal-title":"Trends Pharmacol Sci."},{"key":"9137_CR28","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1097\/HEP.0000000000000237","volume":"79","author":"AD Ladd","year":"2024","unstructured":"Ladd AD, Duarte S, Sahin I, Zarrinpar A. Mechanisms of drug resistance in HCC. Hepatology. 2024;79:926\u2013940.","journal-title":"Hepatology."},{"key":"9137_CR29","doi-asserted-by":"publisher","first-page":"1133308","DOI":"10.3389\/fimmu.2023.1133308","volume":"14","author":"C Chen","year":"2023","unstructured":"Chen C, Wang Z, Ding Y, Qin Y. Tumor microenvironment-mediated immune evasion in hepatocellular carcinoma. Front Immunol. 2023;14:1133308.","journal-title":"Front Immunol."},{"key":"9137_CR30","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1016\/j.jhep.2022.06.012","volume":"77","author":"M Peiseler","year":"2022","unstructured":"Peiseler M, Schwabe R, Hampe J, Kubes P, Heikenwalder M, Tacke F. Immune mechanisms linking metabolic injury to inflammation and fibrosis in fatty liver disease\u2014novel insights into cellular communication circuits. J Hepatol. 2022;77:1136\u20131160.","journal-title":"J Hepatol."},{"key":"9137_CR31","doi-asserted-by":"publisher","first-page":"1070961","DOI":"10.3389\/fimmu.2022.1070961","volume":"13","author":"Q Li","year":"2022","unstructured":"Li Q, Han J, Yang Y, Chen Y. PD-1\/PD-L1 checkpoint inhibitors in advanced hepatocellular carcinoma immunotherapy. Front Immunol. 2022;13:1070961.","journal-title":"Front Immunol."},{"key":"9137_CR32","doi-asserted-by":"publisher","first-page":"108387","DOI":"10.1016\/j.pharmthera.2023.108387","volume":"244","author":"SJ Yu","year":"2023","unstructured":"Yu SJ. Immunotherapy for hepatocellular carcinoma: Recent advances and future targets. Pharmacol Ther. 2023;244:108387.","journal-title":"Pharmacol Ther."},{"key":"9137_CR33","doi-asserted-by":"publisher","first-page":"597","DOI":"10.3390\/ijms25010597","volume":"25","author":"M Shah","year":"2024","unstructured":"Shah M, Sarkar D. HCC-related lncRNAs: roles and mechanisms. Int J Mol Sci. 2024;25:597.","journal-title":"Int J Mol Sci."},{"key":"9137_CR34","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/s12943-020-01188-4","volume":"19","author":"Z Huang","year":"2020","unstructured":"Huang Z, Zhou JK, Peng Y, He W, Huang C. The role of long noncoding RNAs in hepatocellular carcinoma. Mol Cancer. 2020;19:77.","journal-title":"Mol Cancer."}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-025-09137-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10620-025-09137-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-025-09137-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T04:53:30Z","timestamp":1763441610000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10620-025-09137-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,18]]},"references-count":34,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["9137"],"URL":"https:\/\/doi.org\/10.1007\/s10620-025-09137-1","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,18]]},"assertion":[{"value":"6 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}